These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 2486742

  • 1. [Hypoalphalipoproteinemia and atherosclerosis. Genetic and biochemical profile of 10 families].
    Ahumada Ayala M, Jiménez Villanueva C, Cardoso Saldaña G, Sienra Pérez JC, Zamora González J, Posadas Romero C.
    Arch Inst Cardiol Mex; 1989; 59(1):9-18. PubMed ID: 2486742
    [Abstract] [Full Text] [Related]

  • 2. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ, Rubins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ.
    Arch Intern Med; 1996 Jun 10; 156(11):1181-8. PubMed ID: 8639012
    [Abstract] [Full Text] [Related]

  • 3. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.
    Clin Ther; 2007 Aug 10; 29(8):1671-81. PubMed ID: 17919548
    [Abstract] [Full Text] [Related]

  • 4. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.
    Indian Heart J; 2003 Aug 10; 55(3):234-40. PubMed ID: 14560932
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW, Petrasovits A, Stachenko S, MacLean DR, Little JA, Chockalingam A.
    Can J Cardiol; 1999 Apr 10; 15(4):428-33. PubMed ID: 10322252
    [Abstract] [Full Text] [Related]

  • 6. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ.
    J Am Osteopath Assoc; 2002 Jul 10; 102(7):377-84. PubMed ID: 12138952
    [Abstract] [Full Text] [Related]

  • 7. [National study of lipids in coronary patients].
    Roqué F, Amuchástegui LM, Mon G, Giannone C.
    Medicina (B Aires); 1992 Jul 10; 52(1):10-6. PubMed ID: 1343578
    [Abstract] [Full Text] [Related]

  • 8. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M, Raslová K, Rauchová H, Vohnout B, Ptácková K, Frohlich J.
    Physiol Res; 2001 Jul 10; 50(1):1-8. PubMed ID: 11300220
    [Abstract] [Full Text] [Related]

  • 9. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J.
    Can J Cardiol; 1997 Mar 10; 13(3):253-60. PubMed ID: 9117913
    [Abstract] [Full Text] [Related]

  • 10. [Cholesterol bound to high density lipoproteins: critical review of the methods of analysis and personal data].
    Orso Giacone G.
    Ann Osp Maria Vittoria Torino; 1982 Mar 10; 24(7-12):286-306. PubMed ID: 7137764
    [Abstract] [Full Text] [Related]

  • 11. Primary and familial hypoalphalipoproteinemia.
    Third JL, Montag J, Flynn M, Freidel J, Laskarzewski P, Glueck CJ.
    Metabolism; 1984 Feb 10; 33(2):136-46. PubMed ID: 6694557
    [Abstract] [Full Text] [Related]

  • 12. Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias.
    Pirro M, Siepi D, Lupattelli G, Roscini AR, Schillaci G, Gemelli F, Vaudo G, Marchesi S, Pasqualini L, Mannarino E.
    Metabolism; 2003 Apr 10; 52(4):432-6. PubMed ID: 12701054
    [Abstract] [Full Text] [Related]

  • 13. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T, Hanefeld M.
    Exp Clin Endocrinol Diabetes; 2004 Feb 10; 112(2):75-9. PubMed ID: 15031770
    [Abstract] [Full Text] [Related]

  • 14. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb 10; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 15. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP, Pépin GM, Mahley RW.
    Am Heart J; 2003 Dec 10; 146(6):1052-9. PubMed ID: 14660998
    [Abstract] [Full Text] [Related]

  • 16. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV, Pallarés V, Cea-Calvo L, Llisterri JL, Fernández-Pérez C, Martí-Canales JC, Aznar J, Gil-Guillén V, Redón J, Investigators of the PREV-ICTUS Study.
    Curr Med Res Opin; 2008 Mar 10; 24(3):659-70. PubMed ID: 18218194
    [Abstract] [Full Text] [Related]

  • 17. [Prognostic value of high-density lipoproteins in the cardiology unit].
    Sampietro T, Bigazzi F, Dal Pino B, Landi P, Puntoni M, Minichilli F, Bianchi F, Chella E, Carpeggiani C, Bionda A.
    Ital Heart J Suppl; 2004 Sep 10; 5(9):720-6. PubMed ID: 15568610
    [Abstract] [Full Text] [Related]

  • 18. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR, van der Graaf Y, Bots ML, Algra A, Visseren FL, SMART Study Group.
    Eur J Clin Invest; 2009 Aug 10; 39(8):680-8. PubMed ID: 19453647
    [Abstract] [Full Text] [Related]

  • 19. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ, Assmann G, Fruchart JC, Shepherd J, Sirtori C, European Consensus Panel on HDL-C.
    Curr Med Res Opin; 2004 Aug 10; 20(8):1253-68. PubMed ID: 15324528
    [Abstract] [Full Text] [Related]

  • 20. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 10; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.